Butterfly Network (BFLY) Preferred Stock Liabilities (2020)

Butterfly Network (BFLY) reported Preferred Stock Liabilities of $360.9 million for Q4 2020, little changed sequentially from $360.9 million in Q3 2020.

Butterfly Network (BFLY) Preferred Stock Liabilities (2020) Analysis & Trends

Butterfly Network (BFLY) has 1 years of Preferred Stock Liabilities data on file, last reported at $360.9 million in Q4 2020.

  • For the quarter ending Q4 2020, Preferred Stock Liabilities changed N/A year-over-year to $360.9 million; the trailing twelve-month figure through Dec 2020 stood at $360.9 million (changed N/A YoY), and the FY2020 full-year result was $360.9 million, changed 0.0% from the prior year.
  • Preferred Stock Liabilities was little changed at $360.9 million in Q4 2020, from $360.9 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $360.9 million in Q1 2020 to a low of $360.9 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 Butterfly Network 1.79 Bn 1.65 Bn 18.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 360.94 Mn
Sep 30, 2020 360.94 Mn
Jun 30, 2020 360.94 Mn
Mar 31, 2020 360.94 Mn